Apparent bypass of negative selection in CD8+ tumours in CD2-myc transgenic mice.
about
Inflammatory disease and lymphomagenesis caused by deletion of the Myc antagonist Mnt in T cells.Skewed T-cell receptor Vbeta8.2 expression in transgenic CD2-myc induced thymic lymphoma: a role for antigen stimulation in tumour development?TCR v(beta) repertoire restriction and lack of CDR3 conservation implicate TCR-superantigen interactions in promoting the clonal evolution of murine thymic lymphomas.Fas-independent apoptosis in T-cell tumours induced by the CD2-myc transgene
P2860
Apparent bypass of negative selection in CD8+ tumours in CD2-myc transgenic mice.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Apparent bypass of negative selection in CD8+ tumours in CD2-myc transgenic mice.
@en
Apparent bypass of negative selection in CD8+ tumours in CD2-myc transgenic mice.
@nl
type
label
Apparent bypass of negative selection in CD8+ tumours in CD2-myc transgenic mice.
@en
Apparent bypass of negative selection in CD8+ tumours in CD2-myc transgenic mice.
@nl
prefLabel
Apparent bypass of negative selection in CD8+ tumours in CD2-myc transgenic mice.
@en
Apparent bypass of negative selection in CD8+ tumours in CD2-myc transgenic mice.
@nl
P2093
P2860
P356
P1476
Apparent bypass of negative selection in CD8+ tumours in CD2-myc transgenic mice.
@en
P2093
Cameron ER
Campbell M
P2860
P2888
P356
10.1038/BJC.1996.3
P407
P577
1996-01-01T00:00:00Z